Cite
Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability.
MLA
Levinstein, Marjorie R., et al. “Mu Opioid Receptor Activation Mediates (S)-Ketamine Reinforcement in Rats: Implications for Abuse Liability.” Biological Psychiatry, vol. 93, no. 12, June 2023, pp. 1118–26. EBSCOhost, https://doi.org/10.1016/j.biopsych.2022.12.019.
APA
Levinstein, M. R., Carlton, M. L., Di Ianni, T., Ventriglia, E. N., Rizzo, A., Gomez, J. L., Budinich, R. C., Shaham, Y., Airan, R. D., Zarate, C. A., Jr, Bonaventura, J., & Michaelides, M. (2023). Mu Opioid Receptor Activation Mediates (S)-ketamine Reinforcement in Rats: Implications for Abuse Liability. Biological Psychiatry, 93(12), 1118–1126. https://doi.org/10.1016/j.biopsych.2022.12.019
Chicago
Levinstein, Marjorie R, Meghan L Carlton, Tommaso Di Ianni, Emilya N Ventriglia, Arianna Rizzo, Juan L Gomez, Reece C Budinich, et al. 2023. “Mu Opioid Receptor Activation Mediates (S)-Ketamine Reinforcement in Rats: Implications for Abuse Liability.” Biological Psychiatry 93 (12): 1118–26. doi:10.1016/j.biopsych.2022.12.019.